摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-3-溴-5-氰基吡啶 | 477871-32-2

中文名称
2-氨基-3-溴-5-氰基吡啶
中文别名
6-氨基-5-溴烟腈
英文名称
6-amino-5-bromonicotinonitrile
英文别名
2-amino-3-bromo-5-cyanopyridine;6-amino-5-bromopyridine-3-carbonitrile
2-氨基-3-溴-5-氰基吡啶化学式
CAS
477871-32-2
化学式
C6H4BrN3
mdl
——
分子量
198.022
InChiKey
CKUQTHSGTPGGFK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    194-195°
  • 沸点:
    294.4±40.0 °C(Predicted)
  • 密度:
    1.80±0.1 g/cm3(Predicted)
  • 溶解度:
    27.8 [ug/mL]

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    62.7
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • TSCA:
    N
  • 危险等级:
    IRRITANT
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:c87413f9ce30acee0e4a791236104cb6
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 6-Amino-5-bromonicotinonitrile
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 6-Amino-5-bromonicotinonitrile
CAS number: 477871-32-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H4BrN3
Molecular weight: 198

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氨基-3-溴-5-氰基吡啶亚硝酸特丁酯 、 copper dichloride 作用下, 以 乙腈 为溶剂, 反应 3.0h, 以55%的产率得到5-溴-6-氯烟腈
    参考文献:
    名称:
    [EN] OPIOID RECEPTOR ANTAGONISTS
    [FR] ANTAGONISTES DE RECEPTEURS OPIOIDES
    摘要:
    公开了一种化合物的公式(I)(I),其中变量X1至X6,Ra,Rb,R1至R7包括R3',E,p,j,y,z,A,B和C如所述,或者是药用可接受的盐,溶剂化合物,对映体,消旋体,顺反异构体或其混合物,用于治疗、预防或改善肥胖和相关疾病。
    公开号:
    WO2005090337A1
  • 作为产物:
    描述:
    2-氨基-5-氰基吡啶N-溴代丁二酰亚胺(NBS) 作用下, 以 乙腈 为溶剂, 以95%的产率得到2-氨基-3-溴-5-氰基吡啶
    参考文献:
    名称:
    NITROGENOUS CYCLIC COMPOUND AND COLOR CHANGING FILM COMPRISING SAME
    摘要:
    本说明书涉及一种含有氮的化合物,以及包括该化合物的色转换膜、背光单元和显示设备。
    公开号:
    US20200095265A1
点击查看最新优质反应信息

文献信息

  • [EN] SOMATOSTATIN MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE LA SOMATOSTATINE ET UTILISATIONS DE CES DERNIERS
    申请人:CRINETICS PHARMACEUTICALS INC
    公开号:WO2019023278A1
    公开(公告)日:2019-01-31
    Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    本文描述了一些肽类调节剂化合物,制备这类化合物的方法,包含这类化合物的药物组合物和药物,以及利用这类化合物治疗需要调节生长抑素活性的疾病、症状或疾病的方法。
  • NITROGENOUS CYCLIC COMPOUND AND COLOR CHANGING FILM COMPRISING SAME
    申请人:LG CHEM, LTD.
    公开号:US20200095265A1
    公开(公告)日:2020-03-26
    The present specification relates to a compound containing nitrogen, and a color conversion film, a backlight unit, and a display device, including the same.
    本说明书涉及一种含有氮的化合物,以及包括该化合物的色转换膜、背光单元和显示设备。
  • [EN] NOVEL SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS GAMMA SECRETASE MODULATORS<br/>[FR] NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES BICYCLIQUES SUBSTITUÉS EN TANT QUE MODULATEURS DE LA GAMMA-SÉCRÉTASE
    申请人:ORTHO MCNEIL JANSSEN PHARM
    公开号:WO2010089292A1
    公开(公告)日:2010-08-12
    The present invention is concerned with substituted bicyclic heterocyclic compounds of Formula (I) wherein Het1, Het2, A1, A2, A3 and A4 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
    本发明涉及式(I)的取代双环杂环化合物,其中Het1、Het2、A1、A2、A3和A4的含义如权利要求中所定义。根据本发明的化合物可用作γ-分泌酶调节剂。本发明还涉及制备这种新化合物的方法,包含所述化合物作为活性成分的药物组合物,以及将所述化合物用作药物的用途。
  • Heterocycle-substituted Pyridyl Benzothiophenes as Kinase Inhibitors
    申请人:Allergan, Inc.
    公开号:US20160102081A1
    公开(公告)日:2016-04-14
    This invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 4 and X are as defined herein. The compounds of Formula I are useful as receptor tyrosine kinase (RTK) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases.
    这项发明涉及一种具有化学式I的化合物或其药用可接受的盐,其中R1、R2、R3、R4和X如本文所定义。化合物I的用途包括作为受体酪氨酸激酶(RTK)抑制剂,并可用于治疗癌症、血管增生性疾病、纤维化疾病、系膜细胞增生性疾病和代谢性疾病。
  • [EN] INDOLE AND AZAINDOLE MODULATORS OF THE ALPHA 7 NACHR<br/>[FR] MODULATEURS INDOLES ET AZAINDOLES DU NACHR-?7
    申请人:PROXIMAGEN LTD
    公开号:WO2011045353A1
    公开(公告)日:2011-04-21
    This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    这项发明涉及利用式(I)的化合物或其药用可接受盐对α7尼古丁乙酰胆碱受体(nAChR)进行调节。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-